$5.41
-0.13-2.35%
In chiusura: -
$5.52
0.112.02%
After hour: 4:44 PM EDT
Candel Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Candel Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
CADL | Candel Therapeutics | -$0.33 | -$0.17 | — | — | $0.00 | — | — | — | 11/13/2025 | |
CADL | Candel Therapeutics | -$0.74 | -$0.17 | -$0.09 | 47.06% | $0.00 | — | $0.00 | — | 08/14/2025 | |
CADL | Candel Therapeutics | -$0.28 | -$0.24 | $0.13 | 154.17% | $0.00 | — | $0.00 | — | 05/13/2025 | |
CADL | Candel Therapeutics | -$0.38 | -$0.23 | -$0.40 | -73.91% | $0.00 | — | $0.00 | — | 03/13/2025 | |
CADL | Candel Therapeutics | -$0.29 | — | -$0.33 | — | $0.00 | — | $0.00 | — | 11/14/2024 | |
CADL | Candel Therapeutics | -$0.33 | — | -$0.74 | — | $0.00 | — | $0.00 | — | 08/13/2024 | |
CADL | Candel Therapeutics | -$0.30 | — | -$0.28 | — | $0.00 | — | $0.00 | — | 05/14/2024 | |
CADL | Candel Therapeutics | -$0.18 | -$0.16 | -$0.38 | -137.50% | $31.00K | $10.00K | $0.00 | -100.00% | 03/28/2024 | |
CADL | Candel Therapeutics | -$0.30 | -$0.19 | -$0.29 | -52.63% | $31.00K | — | $0.00 | — | 11/09/2023 | |
CADL | Candel Therapeutics | -$0.30 | -$0.30 | -$0.33 | -10.00% | $31.00K | — | $0.00 | — | 08/10/2023 | |
CADL | Candel Therapeutics | -$0.03 | -$0.35 | -$0.30 | 14.29% | $31.00K | — | $0.00 | — | 05/11/2023 | |
CADL | Candel Therapeutics | -$0.23 | -$0.31 | -$0.18 | 41.94% | $31.00K | $20.00K | $31.00K | 55.00% | 03/30/2023 | |
CADL | Candel Therapeutics | -$0.69 | -$0.35 | -$0.30 | 14.29% | $31.00K | $30.00K | $31.00K | 3.33% | 11/10/2022 | |
CADL | Candel Therapeutics | -$0.31 | -$0.41 | -$0.30 | 26.83% | $31.00K | — | $31.00K | — | 08/05/2022 | |
CADL | Candel Therapeutics | -$0.38 | -$0.31 | -$0.30 | 3.23% | $31.00K | — | $31.00K | — | 05/12/2022 | |
CADL | Candel Therapeutics | — | -$0.32 | -$0.23 | 28.12% | — | $10.00K | $31.00K | 210.00% | 03/29/2022 | |
CADL | Candel Therapeutics | -$0.22 | — | -$0.26 | — | $31.00K | — | $31.00K | — | 11/12/2021 | |
CADL | Candel Therapeutics | — | -$0.12 | -$0.31 | -158.33% | — | $20.00K | $31.00K | 55.00% | 09/08/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-14 | $-0.09 | $-0.17 | 47.1 % |
Q1 | 2025-05-13 | $0.13 | $-0.24 | 154.2 % |
Q4 | 2025-03-13 | $-0.40 | $-0.23 | -73.9 % |
Q4 | 2024-03-28 | $-0.38 | $-0.16 | -137.5 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q4 | 2024-03-28 | $0 | $10.00K | -100.0 % |
Q4 | 2023-03-30 | $31.00K | $20.00K | 55.0 % |
Q3 | 2022-11-10 | $31.00K | $30.00K | 3.33 % |
Q4 | 2022-03-29 | $31.00K | $10.00K | 210.0 % |
Si prevede che Candel Therapeutics (CADL) fornisca risultati il novembre 13, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.09, che superato la stima di $-0.17.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.